- Home
- AVTR
AVTR
Avantor Inc.
as 03-28-2025 4:00pm EST
| Founded: | 1904 | Country: | United States |
| Employees: | N/A | City: | RADNOR |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $25.77 | AVG Volume (30 days): | 8.4M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.04 | EPS Growth: | 121.28 |
| 52 Week Low/High: | $15.37 - $28.00 | Next Earning Date: | 04-25-2025 |
| Revenue: | $6,783,600,000 | Revenue Growth: | -2.63% |
| Revenue Growth (this year): | -0.05% | Revenue Growth (next year): | 4.57% |
Stock Insider Trading Activity of Avantor Inc. (AVTR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Eck Steven W | AVTR | SVP & Chief Accounting Officer | Feb 26 '25 | Sell | $17.27 | 5,940 | $103,580.71 | 40,604 |
Latest Avantor Inc. News
AVTR Breaking Stock News: Dive into AVTR Ticker-Specific Updates for Smart Investing
PR Newswire
11 hours ago
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
StockStory
14 hours ago
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch
Zacks
a day ago
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
StockStory
8 days ago
3 Healthcare Stocks Walking a Fine Line
StockStory
9 days ago
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)
PR Newswire
11 days ago
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
Insider Monkey
15 days ago
Why Avantor Inc. (AVTR) Went Down On Wednesday?
Insider Monkey
16 days ago
Avantor, Inc. (AVTR): Among the Undervalued Stocks with the Highest Upside Potential
Compare AVTR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVTR Avantor Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.